Michael F. Mahoney, Chairman, President & CEO at BOSTON SCIENTIFIC CORP (BSX), sold 328,886 shares at $102.13 ($33.7M) on 2025-05-01, disclosed to the SEC on 2025-05-05.
Scheduled sale ($33.7M) by Chairman, President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.13 | 91,282 | $9.3M | 27.7% |
| 2 | $102.13 | 91,282 | $9.3M | 27.7% |
| 3 | $102.92 | 73,161 | $7.5M | 22.3% |
| 4 | $102.92 | 73,161 | $7.5M | 22.3% |
| Total | $102.48 avg | 328,886 | $33.7M | 100% |
| Filing → |
| BSX | SELL | 2025-04-02 | $32.9M | — | Filing → |
| CVS | BUY | 2025-02-19 | $2.0M | — | Filing → |
| BSX | SELL | 2024-11-07 | $27.6M | — | Filing → |